Home » Paradigm Partner Completes FDA Submission for Retimax
Paradigm Partner Completes FDA Submission for Retimax
Paradigm Medical Industries, Inc. announced that it has been notified by its Italian partner, Costruzione Strumenti Oftalmici, that all necessary documents
have been completed and submitted to the United States Food and Drug Administration (FDA) for the Retimax, also known as the Paramax.
CNNMoney
CNNMoney
Upcoming Events
-
07May
-
14May
-
23May
-
30May
-
21Oct